Daclatasvir
Products Daclatasvir was approved in the EU in 2014 and in many countries in 2015 in film-coated tablet form (Daklinza, Bristol-Myers Squibb). Structure and properties Daclatasvir (C40H50N8O6, Mr = 738.9 g/mol) is present in the drug product as daclatasvir dihydrochloride. Effects Daclatasvir (ATC J05AX14) has antiviral properties. The effects are due to binding to the … Daclatasvir
